We can’t show the full text here under this license.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are important for managing obesity and type 2 diabetes mellitus (T2DM).
- GLP-1 RAs mimic the effects of the natural hormone GLP-1 to help regulate blood sugar levels and promote weight loss.
- They may offer additional benefits for cardiovascular and kidney health.
- Recent clinical studies suggest GLP-1 RAs could be effective for both diabetic and nondiabetic individuals.
- The review highlights the need for further research to clarify the broader benefits of GLP-1 RAs.
Simplified